| Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders S Delhaye, B Bardoni Molecular Psychiatry 26 (9), 4570-4582, 2021 | 125 | 2021 |
| Involvement of phosphodiesterase 2A activity in the pathophysiology of fragile X syndrome T Maurin, F Melancia, M Jarjat, L Castro, L Costa, S Delhaye, A Khayachi, ... Cerebral cortex 29 (8), 3241-3252, 2019 | 45 | 2019 |
| New Insights Into the Role of Cav2 Protein Family in Calcium Flux Deregulation in Fmr1-KO Neurons S Castagnola, S Delhaye, A Folci, A Paquet, F Brau, F Duprat, M Jarjat, ... Frontiers in Molecular Neuroscience 11, 342, 2018 | 24 | 2018 |
| Reduction of Fmr1 mRNA levels rescues pathological features in cortical neurons in a model of FXTAS M Drozd, S Delhaye, T Maurin, S Castagnola, M Grossi, F Brau, M Jarjat, ... Molecular Therapy Nucleic Acids 18, 546-553, 2019 | 17 | 2019 |
| Fragile X Syndrome as an interneuronopathy: a lesson for future studies and treatments A Tempio, A Boulksibat, B Bardoni, S Delhaye Frontiers in Neuroscience 17, 1171895, 2023 | 11 | 2023 |
| Agonist-induced functional analysis and cell sorting associated with single-cell transcriptomics characterizes cell subtypes in normal and pathological brain S Castagnola, J Cazareth, K Lebrigand, M Jarjat, V Magnone, S Delhaye, ... Genome Research 30 (11), 1633-1642, 2020 | 8 | 2020 |
| Defects in AMPAR trafficking and microglia activation underlie socio-cognitive deficits associated to decreased expression of phosphodiesterase 2 a S Delhaye, M Jarjat, A Boulksibat, C Sanchez, A Tempio, A Turtoi, ... Neurobiology of Disease 191, 106393, 2024 | 7 | 2024 |
| New insights into the role of Cav2 protein family in calcium flux deregulation in Fmr1-KO neurons. Front Mol Neurosci 11: 342 S Castagnola, S Delhaye, A Folci, A Paquet, F Brau, F Duprat, M Jarjat, ... | 5 | 2018 |
| Rôle de la phosphodiestérase 2A dans la physiopathologie du syndrome de l’X fragile S Delhaye Université Côte d'Azur, 2021 | | 2021 |
| Agonist-induced Functional Analysis and Cell Sorting, a novel tool to select and analyze neurons: Fragile X as a proof of concept S Castagnola, J Cazareth, K Lebrigand, M Jarjat, V Magnone, S Delhaye, ... bioRxiv, 2020.04. 20.050997, 2020 | | 2020 |
| Modulation of cGMP and cAMP as a new therapeutic target for Fragile X Syndrome B Bardoni, V Trezza, S Martin, P Vincent, L Ciranna, M Jarjat, S Delhaye, ... EUROPEAN JOURNAL OF HUMAN GENETICS 27, 548-548, 2019 | | 2019 |
